PolyVar Yellow 275 mg Bee-hive Strip

Country: United Kingdom

Language: English

Source: VMD (Veterinary Medicines Directorate)

Active ingredient:

Flumethrin

Available from:

Bayer plc

ATC code:

QP53AC05

INN (International Name):

Flumethrin

Pharmaceutical form:

Bee-hive strip

Prescription type:

AVM-GSL - Authorised Veterinary Medicine – General Sales List

Therapeutic group:

Bees

Therapeutic area:

Ectoparasiticide

Authorization status:

Authorized

Authorization date:

2017-03-07

Summary of Product characteristics

Revised: May 2018
AN: 02445/2017
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
PolyVar Yellow 275 mg bee-hive strip
[AT, BE, BG, CY, CZ, DE, EE, EL, FR,
HR, HU, IE, IT, LU, NL, PL, RO, SI, SK,
UK]
Polyvar 275 mg bee-hive strip
[DK, ES, PT, SE]
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
One bee-hive strip contains
ACTIVE SUBSTANCE:
Flumethrin
275 mg
EXCIPIENTS:
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Bee-hive strip
Yellow, plastic strips with 15 holes
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Honey bee (_Apis mellifera_)
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the treatment of varroosis in honey bees caused by flumethrin
sensitive _Varroa _
_destructor _mites.
4.3
CONTRAINDICATIONS
Do not use in cases of known resistance against pyrethroids as
described in section
4.4, Special warnings.
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
All colonies located on the same apiary should be treated
simultaneously.
The product should be used as part of an integrated varroa control
programme.
As an effective method to reduce the risk of resistance selection
PolyVar Yellow – as
for other acaricides – should not be used in consecutive years.
Instead, strict rotation
with products containing active substances from other chemical classes
should be
Page 1 of 6
Revised: May 2018
AN: 02445/2017
applied. Depending on the regional resistance situation a longer
treatment break than
one year may be necessary. As flumethrin and tau-fluvalinate belong to
the same
class they are not suitable for rotation with each other.
Inappropriate use of the product could result in an increased risk of
resistance
development and could ultimately result in ineffective therapy and
colony losses.
In general, it is recommended to test acaricide susceptibility at a
regional level, e.g.
by bioassays or molecular analysis (PCR). In the case of existing
resistance to
pyrethroids PolyVar Yellow should not be applied. Where resistance to
pyrethroids
has been seen in the pas